Literature DB >> 21641054

Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics.

Alla Khashper1, Tamar Gaspar, Mali Azencot, Idit Dobrecky-Mery, Nathan Peled, Basil S Lewis, David A Halon.   

Abstract

BACKGROUND: Visceral abdominal adipose tissue (VAT) may play an active role in the progression of coronary atherosclerosis. We examined the relation between VAT, non-alcoholic fatty liver disease and extent of coronary atheroma in patients with type 2 diabetes mellitus but no known coronary artery disease.
METHODS: Coronary artery calcium and area, distribution and thickness of upper abdominal fat were measured in selected axial cross-sections from non-enhanced computed tomography (CT) scans of the chest. Coronary atheroma was assessed visually on a per vessel basis from 64 slice CT angiography using axial views and multi-format reconstructions. Fatty liver was diagnosed when liver density was <40 Hounsfield units (HU) or ≥10 HU below spleen density.
RESULTS: The area of VAT was increased in patients with versus without multi-vessel coronary artery plaque (237.0 ± 101.4 vs 179.2 ± 79.4 mm(2), p<0.001). Waist circumference (101.6 ± 12.3 versus 95.3 ± 13.8 cm) and internal abdominal diameter (218.7 ± 33.0 vs 194.6 ± 25.7 mm) (both p<0.001) were increased in patients with multi-vessel plaque whereas subcutaneous fat was unrelated to coronary plaque. Presence of fatty liver (93/318 patients, 29.2%) did not correlate with presence or extent of coronary plaque. The correlation of VAT with multi-vessel plaque although nominally independent of the metabolic syndrome (p=0.04) was not independent of waist circumference.
CONCLUSION: In asymptomatic subjects with DM and no history of CAD area of VAT correlated with the presence and extent of coronary atheroma but as a risk predictor added little independent information to that obtained by more readily obtainable measures of adiposity-waist circumference and internal abdominal diameter.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21641054     DOI: 10.1016/j.ijcard.2011.05.059

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Abdominal fat distribution and carotid atherosclerosis in a general population: a semi-automated method using magnetic resonance imaging.

Authors:  Amir Reza Radmard; Hossein Poustchi; Leila Ansari; Faezeh Khorasanizadeh; Ali Yoonessi; Amir Pejman Hashemi Taheri; Mohammad Sadegh Rahmanian; Elham Jafari; Reza Malekzadeh; Shahin Merat
Journal:  Jpn J Radiol       Date:  2016-03-25       Impact factor: 2.374

2.  Visceral adipose tissue area is associated with coronary stenosis and noncalcified plaques.

Authors:  S J Kang; D Kim; H E Park; S H Choi; S-Y Choi; W Lee; J S Kim; S-H Cho
Journal:  Int J Obes (Lond)       Date:  2013-06-10       Impact factor: 5.095

3.  Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.

Authors:  Devjit Tripathy; Giuseppe Daniele; Teresa V Fiorentino; Zandra Perez-Cadena; Alberto Chavez-Velasquez; Subhash Kamath; Paolo Fanti; Christopher Jenkinson; Francesco Andreozzi; Massimo Federici; Amalia Gastaldelli; Ralph A Defronzo; Franco Folli
Journal:  Diabetologia       Date:  2013-06-30       Impact factor: 10.122

4.  Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people.

Authors:  Ki-Chul Sung; Sarah H Wild; Hyon Joo Kwag; Christopher D Byrne
Journal:  Diabetes Care       Date:  2012-07-24       Impact factor: 19.112

5.  Contribution of subcutaneous abdominal fat on ultrasonography to carotid atherosclerosis in patients with type 2 diabetes mellitus.

Authors:  Chan-Hee Jung; Bo-Yeon Kim; Kyu-Jin Kim; Sang-Hee Jung; Chul-Hee Kim; Sung-Koo Kang; Ji-Oh Mok
Journal:  Cardiovasc Diabetol       Date:  2014-03-28       Impact factor: 9.951

Review 6.  New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis.

Authors:  Georgiana-Diana Cazac; Cristina-Mihaela Lăcătușu; Cătălina Mihai; Elena-Daniela Grigorescu; Alina Onofriescu; Bogdan-Mircea Mihai
Journal:  Life (Basel)       Date:  2022-08-04

7.  Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.

Authors:  Ian J Neeland; Colby R Ayers; Anand K Rohatgi; Aslan T Turer; Jarett D Berry; Sandeep R Das; Gloria L Vega; Amit Khera; Darren K McGuire; Scott M Grundy; James A de Lemos
Journal:  Obesity (Silver Spring)       Date:  2013-05-19       Impact factor: 5.002

8.  Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort.

Authors:  Ki-Chul Sung; Young-Hyo Lim; Sungha Park; Seok-Min Kang; Jeong Bae Park; Byung-Jin Kim; Jin-Ho Shin
Journal:  Cardiovasc Diabetol       Date:  2013-11-05       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.